|
MAGOH expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.418980E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.918190E-03 |
| Normal-vs-Stage2 |
3.359800E-01 |
| Normal-vs-Stage3 |
1.537560E-01 |
| Normal-vs-Stage4 |
1.406150E-04 |
| Stage1-vs-Stage2 |
3.126200E-01 |
| Stage1-vs-Stage3 |
1.502160E-01 |
| Stage1-vs-Stage4 |
1.731180E-01 |
| Stage2-vs-Stage3 |
9.943000E-01 |
| Stage2-vs-Stage4 |
7.187600E-02 |
| Stage3-vs-Stage4 |
1.109520E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.281500E-03 |
| Normal-vs-AfricanAmerican |
3.403100E-04 |
| Normal-vs-Asian |
2.874300E-02 |
| Caucasian-vs-AfricanAmerican |
9.980900E-03 |
| Caucasian-vs-Asian |
3.319600E-01 |
| AfricanAmerican-vs-Asian |
7.541000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.742400E-02 |
| Normal-vs-Female |
1.70197999999067E-05 |
| Male-vs-Female |
3.836200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.842400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.103900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.475200E-03 |
| Normal-vs-Age(81-100Yrs) |
5.168000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.936000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.569200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.654200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.256400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.930800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.979600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.935900E-03 |
| Normal-vs-Grade 2 |
2.595800E-04 |
| Normal-vs-Grade 3 |
1.321390E-01 |
| Normal-vs-Grade 4 |
7.396000E-03 |
| Grade 1-vs-Grade 2 |
6.630400E-02 |
| Grade 1-vs-Grade 3 |
5.175800E-03 |
| Grade 1-vs-Grade 4 |
4.982100E-02 |
| Grade 2-vs-Grade 3 |
1.506260E-02 |
| Grade 2-vs-Grade 4 |
8.251600E-01 |
| Grade 3-vs-Grade 4 |
1.113420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.23750000000389E-06 |
| Normal-vs-ccB subtype |
4.004200E-01 |
| ccA subtype-vs-ccB subtype |
1.50910000051852E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.001800E-02 |
| Normal-vs-N1 |
4.445600E-01 |
| N0-vs-N1 |
8.631800E-01 |
|
|
